Monotherapy to polytherapy: Antiepileptic drug conversions through the spectrum of epilepsy care

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The process of conversion between AED monotherapies is frequently necessary in epilepsy care, yet little practical guidance is available to practitioners. This article introduces an issue of Current Neuropharmacology devoted to the theme of AED conversions and related issues. In this series of articles, we reviewed the role of AED monotherapy in newly diagnosed epilepsy, the practice of transitional polytherapy during AED monotherapy conversions in patients experiencing breakthrough seizures or adverse effects, chronic maintenance polytherapy for refractory epilepsy, and the related topics of strategies for minimizing adverse effects, appropriate blood level monitoring, and patient-related factors in AED conversions. Successful conversion between AED monotherapies and polytherapy drug sequencing requires that practitioners possess and apply a thorough knowledge of epilepsy, AED pharmacology, and clinical reasoning, while being sensitive and reactive to patient reported adverse effects of treatment.

Original languageEnglish (US)
Pages (from-to)75-76
Number of pages2
JournalCurrent Neuropharmacology
Volume7
Issue number2
DOIs
StatePublished - 2009

Fingerprint

Anticonvulsants
Epilepsy
Neuropharmacology
Clinical Pharmacology
Physiologic Monitoring
Combination Drug Therapy
Seizures
Maintenance
Therapeutics

Keywords

  • Antiepileptic drugs
  • Conversion
  • Epilepsy
  • Monotherapy
  • Polytherapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Neurology
  • Pharmacology

Cite this

Monotherapy to polytherapy : Antiepileptic drug conversions through the spectrum of epilepsy care. / St Louis, Erik K.

In: Current Neuropharmacology, Vol. 7, No. 2, 2009, p. 75-76.

Research output: Contribution to journalArticle

@article{290763dba5764a878c4dfd87677f67a3,
title = "Monotherapy to polytherapy: Antiepileptic drug conversions through the spectrum of epilepsy care",
abstract = "The process of conversion between AED monotherapies is frequently necessary in epilepsy care, yet little practical guidance is available to practitioners. This article introduces an issue of Current Neuropharmacology devoted to the theme of AED conversions and related issues. In this series of articles, we reviewed the role of AED monotherapy in newly diagnosed epilepsy, the practice of transitional polytherapy during AED monotherapy conversions in patients experiencing breakthrough seizures or adverse effects, chronic maintenance polytherapy for refractory epilepsy, and the related topics of strategies for minimizing adverse effects, appropriate blood level monitoring, and patient-related factors in AED conversions. Successful conversion between AED monotherapies and polytherapy drug sequencing requires that practitioners possess and apply a thorough knowledge of epilepsy, AED pharmacology, and clinical reasoning, while being sensitive and reactive to patient reported adverse effects of treatment.",
keywords = "Antiepileptic drugs, Conversion, Epilepsy, Monotherapy, Polytherapy",
author = "{St Louis}, {Erik K}",
year = "2009",
doi = "10.2174/157015909788848910",
language = "English (US)",
volume = "7",
pages = "75--76",
journal = "Current Neuropharmacology",
issn = "1570-159X",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Monotherapy to polytherapy

T2 - Antiepileptic drug conversions through the spectrum of epilepsy care

AU - St Louis, Erik K

PY - 2009

Y1 - 2009

N2 - The process of conversion between AED monotherapies is frequently necessary in epilepsy care, yet little practical guidance is available to practitioners. This article introduces an issue of Current Neuropharmacology devoted to the theme of AED conversions and related issues. In this series of articles, we reviewed the role of AED monotherapy in newly diagnosed epilepsy, the practice of transitional polytherapy during AED monotherapy conversions in patients experiencing breakthrough seizures or adverse effects, chronic maintenance polytherapy for refractory epilepsy, and the related topics of strategies for minimizing adverse effects, appropriate blood level monitoring, and patient-related factors in AED conversions. Successful conversion between AED monotherapies and polytherapy drug sequencing requires that practitioners possess and apply a thorough knowledge of epilepsy, AED pharmacology, and clinical reasoning, while being sensitive and reactive to patient reported adverse effects of treatment.

AB - The process of conversion between AED monotherapies is frequently necessary in epilepsy care, yet little practical guidance is available to practitioners. This article introduces an issue of Current Neuropharmacology devoted to the theme of AED conversions and related issues. In this series of articles, we reviewed the role of AED monotherapy in newly diagnosed epilepsy, the practice of transitional polytherapy during AED monotherapy conversions in patients experiencing breakthrough seizures or adverse effects, chronic maintenance polytherapy for refractory epilepsy, and the related topics of strategies for minimizing adverse effects, appropriate blood level monitoring, and patient-related factors in AED conversions. Successful conversion between AED monotherapies and polytherapy drug sequencing requires that practitioners possess and apply a thorough knowledge of epilepsy, AED pharmacology, and clinical reasoning, while being sensitive and reactive to patient reported adverse effects of treatment.

KW - Antiepileptic drugs

KW - Conversion

KW - Epilepsy

KW - Monotherapy

KW - Polytherapy

UR - http://www.scopus.com/inward/record.url?scp=70349673426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349673426&partnerID=8YFLogxK

U2 - 10.2174/157015909788848910

DO - 10.2174/157015909788848910

M3 - Article

C2 - 19949564

AN - SCOPUS:70349673426

VL - 7

SP - 75

EP - 76

JO - Current Neuropharmacology

JF - Current Neuropharmacology

SN - 1570-159X

IS - 2

ER -